Literature DB >> 29726378

Anti-PD-1 antibody treatment for melanoma.

Antoni Ribas1, John M Kirkwood2, Keith T Flaherty3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29726378     DOI： 10.1016/S1470-2045(18)30202-X

Source DB:  PubMed          Journal:  Lancet Oncol        ISSN： 1470-2045            Impact factor:   41.316


× No keyword cloud information.
  4 in total

1.  Immune Characters and Plasticity of the Sentinel Lymph Node in Colorectal Cancer Patients.

Authors:  Xiaoyun Li; Jingling Tang; Hang Du; Xinjun Wang; Liyun Wu; Pingsheng Hu; Hua Zhang; Ruyi Zhang; Yuan Yang
Journal:  J Immunol Res       Date:  2021-08-18       Impact factor: 4.818

2.  Fecal microbiota transplant overcomes resistance to anti-PD-1 therapy in melanoma patients.

Authors:  Diwakar Davar; Amiran K Dzutsev; Giorgio Trinchieri; Hassane M Zarour; John A McCulloch; Richard R Rodrigues; Joe-Marc Chauvin; Robert M Morrison; Richelle N Deblasio; Carmine Menna; Quanquan Ding; Ornella Pagliano; Bochra Zidi; Shuowen Zhang; Jonathan H Badger; Marie Vetizou; Alicia M Cole; Miriam R Fernandes; Stephanie Prescott; Raquel G F Costa; Ascharya K Balaji; Andrey Morgun; Ivan Vujkovic-Cvijin; Hong Wang; Amir A Borhani; Marc B Schwartz; Howard M Dubner; Scarlett J Ernst; Amy Rose; Yana G Najjar; Yasmine Belkaid; John M Kirkwood
Journal:  Science       Date:  2021-02-05       Impact factor: 47.728

3.  Overcoming PD-1 Blockade Resistance with CpG-A Toll-Like Receptor 9 Agonist Vidutolimod in Patients with Metastatic Melanoma.

Authors:  Antoni Ribas; Theresa Medina; John M Kirkwood; Yousef Zakharia; Rene Gonzalez; Diwakar Davar; Bartosz Chmielowski; Katie M Campbell; Riyue Bao; Heather Kelley; Aaron Morris; David Mauro; James E Wooldridge; Jason J Luke; George J Weiner; Arthur M Krieg; Mohammed M Milhem
Journal:  Cancer Discov       Date:  2021-12-01       Impact factor: 39.397

Review 4.  The Anti-PD-1/PD-L1 Immunotherapy for Gastric Esophageal Cancer: A Systematic Review and Meta-Analysis and Literature Review.

Authors:  Ke Chen; Xiao Wang; Liu Yang; Zheling Chen
Journal:  Cancer Control       Date:  2021 Jan-Dec       Impact factor: 3.302
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.